Recommended Presentation and Treatment Approach for Suspected Wilms Tumor
Patients with suspected Wilms tumor should undergo immediate abdominal ultrasound followed by comprehensive cross-sectional imaging, with treatment involving a multidisciplinary approach of primary surgical resection followed by risk-stratified adjuvant chemotherapy with actinomycin D and other agents based on staging and histology. 1, 2
Diagnostic Approach
Initial Presentation
- Common presentations:
- Abdominal mass (often painless)
- Abdominal pain
- Hematuria
- Hypertension (due to renin production)
- Fever (may indicate tumor-related inflammatory response or necrosis) 3
Diagnostic Workup
Imaging studies:
- Abdominal ultrasound (first-line imaging)
- CT scan or MRI of abdomen/pelvis (to assess tumor extent, bilateral involvement)
- Chest imaging (to evaluate for metastatic disease)
Laboratory studies:
- Complete blood count
- Renal function tests
- Urinalysis
- Consider tumor lysis markers if large tumor burden 3
Genetic testing:
- Indicated for all patients with bilateral Wilms tumors
- Should include methylation and copy-number analysis of chromosome 11p15.5
- Sequencing of WT1 and other predisposition genes (REST, TRIM28, DIS3L2, CTR9) 1
- Particularly important for patients with epithelial-predominant histology (strong association with TRIM28 pathogenic variants) 1
Treatment Approach
Surgical Management
- Primary nephrectomy is the standard approach in North America 2, 4
- Complete resection with lymph node sampling
- Careful examination of contralateral kidney
- Avoid tumor rupture during surgery (affects staging)
- Preserve renal function when possible, especially in bilateral disease 5
Chemotherapy
- Adjuvant chemotherapy based on stage and histology:
Radiation Therapy
- Indicated for:
- Higher stage disease (stage III and IV)
- Unfavorable histology
- Residual disease after surgery 2
Special Considerations
Bilateral Wilms Tumor
- Requires more complex management approach
- Nephron-sparing surgery when feasible
- Neoadjuvant chemotherapy often used to reduce tumor size before surgery
- More intensive surveillance recommended (abdominal ultrasounds every 3 months until at least 8 years of age) 1
Genetic Predisposition Syndromes
- Patients with identified predisposition syndromes require:
- Genetic counseling
- Cascade testing for first-degree family members
- Ongoing surveillance with renal ultrasound every 3 months until at least 8 years of age 1
Management of Complications
- Fever management:
- Complete blood count to assess for neutropenia
- Blood cultures from all central line lumens
- Empiric antibiotics for neutropenic fever
- Consider tumor lysis syndrome as potential cause 3
Treatment Outcomes and Follow-up
- Five-year survival exceeds 90% for favorable histology with appropriate treatment 2
- Long-term follow-up needed to monitor for:
- Renal function
- Cardiomyopathy (from anthracycline therapy)
- Secondary malignancies
- Recurrence 4
Pitfalls to Avoid
- Delayed diagnosis - Any child with an abdominal mass should prompt immediate imaging
- Tumor rupture during surgery (increases stage and treatment intensity)
- Missing bilateral disease - thorough examination of contralateral kidney essential
- Inadequate genetic evaluation - particularly important for bilateral disease and patients with epithelial-predominant histology
- Failure to involve pediatric oncology - all patients should be managed by a multidisciplinary team with experience in pediatric renal tumors 2